Report - INC424/ruxolitinib/Jakavi® - ClinicalTrials.gov · 2018. 12. 19. · INC424/ruxolitinib/Jakavi® Protocol CINC424B2001X / NCT02292446 An open-label, multi-center, Expanded Treatment

Please pass captcha verification before submit form